Managing Essential and Systolic High Blood Pressure

Felodipin Hexal is commonly used for sustained condition support of persistently elevated arterial pressure, relevant in conditions such as common essential hypertension and isolated systolic hypertension often seen in older adults. This application is used to provide a key therapeutic benefit by assisting with managing symptoms related to systemic imbalance, which may assist with reducing the systemic burden that contributes to the development of serious cardiovascular issues.

The medication is applied across therapeutic domains involving heightened pressure, and its established uses include treating high blood pressure and chest pain (angina). This consistent control contributes to improved day-to-day comfort and stability by reducing sustained pressure-related physiological strain.

---

Quick Fact: Sustained Symptom Support

Property	Description
Primary Therapeutic Domain	Sustained management of hypertension
Symptom Focus	Symptoms related to systemic imbalance
Clinical Context	Long-term, supportive therapy for chronic conditions
Patient Benefit	Easing overall symptom load
Use Classification	Relevant for easing symptoms associated with pressure and ischemia

---

Prophylaxis of Chronic Stable Angina Pectoris

The medication is commonly used as a long-acting supportive agent for patients with chronic stable angina, which is chest discomfort predictably triggered by physical effort. Felodipin Hexal is relevant for easing the symptomatic relief of exertional chest discomfort, is applied in addressing symptoms linked to organ-specific functional stress, and thereby contributes to easing distress associated with anginal attacks, which may assist with maintaining functional stability. It is used as a treatment for mild-to-moderate hypertension when used alone, and provides essential support as a component of multi-drug regimens for more complex or severe hypertension.

Regulatory References

1. NIH MedlinePlus overview

Who Can and Cannot Use Felodipin Hexal?

Felodipin Hexal's eligibility is strictly governed by regulatory classifications, defining which adult populations are permitted to use the medicine and which are excluded.

---

Absolute Contraindications (Must Not Use)

Use is prohibited for patients with a known hypersensitivity to felodipine or any component of the formulation. It is also contraindicated in acute cardiovascular conditions such as acute myocardial infarction, unstable angina pectoris, decompensated heart failure, and the presence of dynamic cardiac outflow obstruction. Felodipin is contraindicated in women who are pregnant. Use is also prohibited in patients with severe hepatic impairment (liver failure).

---

Eligibility Restrictions and Special Populations

• The medicine's safety and efficacy have not been established in the pediatric population (children and adolescents), and its use is not recommended in this age group.
• For older adults, use is conditional, and regulatory guidance specifies starting with the lowest available dose.
• Patients with mild to moderate hepatic impairment also require conditional use and reduced initial dosing.
• Treatment is not recommended for women who are breastfeeding.
• Dose adjustment is generally not required for patients with renal impairment.

Interactions with other medicines and products

Felodipine's interaction profile is significantly defined by its metabolism through the CYP3A4 enzyme system. The official regulatory documents categorize interactions based on their effect on the drug's concentration in the body.

---

Pharmacokinetic Interactions

Interaction Type	Interacting Medicines/Products (Examples)	Regulatory Constraint/Requirement
CYP3A4 Inhibitors (Increase Felodipine levels)	Azole antifungals (Itraconazole), Macrolide antibiotics (Erythromycin), Cimetidine	Avoid co-administration or use with extreme caution; may increase effects
CYP3A4 Inducers (Decrease Felodipine levels)	Antiepileptic drugs (Phenytoin, Carbamazepine), Rifampicin, St. John's Wort	Avoid co-administration; may result in loss of efficacy

---

Other Clinically Relevant Interactions

Co-administration with other blood pressure-lowering agents may result in an additive effect, leading to excessive blood pressure reduction. Close monitoring for this potentiated effect is advised in official labeling.

Felodipine can also affect the concentration of other co-administered drugs. For instance, regulatory documents note that felodipine may increase the plasma levels of the immunosuppressant Tacrolimus, requiring therapeutic drug monitoring and potential dose adjustment for Tacrolimus.

Food and Product Interactions

Grapefruit and grapefruit juice are explicitly listed in regulatory information as being prohibited during treatment because they inhibit CYP3A4, causing a clinically significant increase in felodipine's concentration and effect. This restriction applies throughout the course of therapy.

How Felodipin Hexal Works

Felodipin Hexal, a dihydropyridine calcium channel blocker, acts by selectively influencing specific ion channels within the vascular system. Its mechanistic action focuses on regulating the contraction state of vascular smooth muscle.

---

Modulation of Vascular L-Type Calcium Channels

This domain involves Felodipin's primary target: the L-type voltage-gated calcium channels found predominantly in the smooth muscle cells of arterial walls. Felodipin acts by binding to these channels, inhibiting the influx of calcium ions (Ca^2+) into the cells.

---

Pathways to Arteriolar Smooth Muscle Relaxation

Inhibition of Ca^2+ entry disrupts the critical signaling cascade required for muscle contraction. The resulting reduced intracellular calcium concentration prevents activation of myosin light-chain kinase. This mechanism limits the interaction between myosin and actin, inducing relaxation of the arterial smooth muscle cells and subsequent vasodilation. This action facilitates a decrease in systemic vascular resistance.

---

Selective Circulatory Pathway Adjustment

The mechanism demonstrates selectivity for the peripheral arterioles over the myocardium and venous tissue. This pathway adjustment contributes to systemic arterial relaxation, resulting in a reduction of peripheral vascular resistance (afterload) and exhibiting selectivity over myocardial tissue function.

How to Use Felodipin Hexal

Felodipine is formulated as an extended-release tablet for oral administration, establishing the definitive route for its therapeutic application. The extended-release design mandates a once daily frequency pattern to ensure continuous systemic delivery of the active substance, supporting its role in long-term cardiovascular management.

---

Standard Adult Dosing and Administration

The medication is typically initiated at a low dose and adjusted gradually, with dose adjustments generally spaced by at least two weeks to allow for stabilization of the extended-release profile.

Indication	Standard Starting Dose (Once Daily)	Maximum Daily Dose
Hypertension	2.5 mg or 5 mg	10 mg
Chronic Stable Angina	5 mg	10 mg

To ensure the correct function of the tablet and consistent absorption, the medication must be swallowed whole with water. It is a critical administration constraint that the extended-release tablets must not be crushed, split, or chewed, as this action would compromise the sustained-release properties. The tablet may be taken either without food or with a light meal, and its use is strictly conditioned by the required avoidance of grapefruit juice.

---

Population-Specific Usage

Official prescribing information stipulates dose adjustments for specific patient populations:

• For older adults (geriatric patients), treatment is typically initiated at the lowest dose of 2.5 mg once daily.
• In patients with impaired liver function (hepatic impairment), the maximum daily dose is generally restricted to 5 mg once daily.
• No initial dosage adjustment is usually necessary for patients with impaired kidney function.

Research Evidence / Overview of Studies for Felodipin Hexal

Evidence for Use in Essential Hypertension

Research has explored the compound's influence on high blood pressure through numerous Randomized Controlled Trials (RCTs) and comprehensive systematic reviews. These investigations were primarily focused on adults with essential hypertension, a condition where symptoms may vary in intensity. Studies examined various methods for administration, assessing the compound when used alone (monotherapy) and in combination with other blood pressure treatments.

The key outcomes monitored in these trials were changes in blood pressure, specifically the Systolic and Diastolic measurements. Research has explored short-term changes in blood pressure, while longer studies spanning up to one year have been conducted to observe effects on structural markers such as the Left Ventricular Mass Index (LVMI). Findings describe patterns observed in the studies related to the measured changes in blood pressure and the achievement of pre-specified blood pressure targets during the observation periods. One large, long-term trial specifically involving patients in China indicated that adding this compound to an existing low-dose diuretic was associated with observed reductions in the incidence of stroke and other cardiovascular events.

Evidence for Use in Chronic Stable Angina

The compound was evaluated in settings exploring temporary physiological imbalance, specifically for people with chronic stable angina pectoris, a condition characterized by episodic manifestations of chest discomfort triggered by physical effort. These studies primarily used randomized and crossover designs.

Research explored short-term symptom changes, monitoring outcomes related to physical discomfort. Studies tracked patient-reported outcomes describing perceived discomfort, such as the weekly frequency of anginal attacks and the use of rescue medication. Objective measurements was observed in trials that examined functional capacity, specifically changes in exercise duration and tolerance during stress testing. Trials reported how symptoms evolved in the observed populations, and findings describe patterns observed in symptom measures and changes in measured exercise capacity.

Areas of Research Uncertainty and Gaps

While a significant volume of research exists, evidence highlights what is known—and what is still uncertain. Long-term effects are not fully established for the compound’s specific influence on hard clinical outcomes (like stroke or heart attack) when used as monotherapy, as much of the most comprehensive long-term data for the drug class is pooled from meta-analyses. The results apply only to the populations studied, and data for certain groups remain insufficient, especially for specific complex subgroups or children. Evidence quality varies across studies, particularly in areas like angina research, where follow-up durations were limited and often focused on short-term symptomatic change rather than preventing serious events.

Key Studies & References

1. Felodipine Event Reduction Study (FEVER): trial design and baseline data
2. Drug Class Review on Calcium Channel Blockers (Update #2, 2005) - Review of Felodipine trials including VHeFT III

Common questions about Felodipin Hexal (FAQ)

Q: How long does it usually take to see a noticeable change in blood pressure after starting this medicine?

Official data indicates that the blood pressure-lowering action typically starts within 2 to 5 hours of taking the tablet. Because Felodipin Hexal is an extended-release formulation, its full therapeutic effect is designed to be sustained over a 24-hour period.

Q: Is it true that it can take a few weeks to feel the full effect of Felodipin Hexal?

While the blood pressure effect begins quickly, the official product information notes that the most common side effect, peripheral edema (swelling of the extremities), usually appears within 2 to 3 weeks of starting therapy. This observation suggests that the body requires this time frame to fully adjust to the medication.

Q: Is it normal to experience heart palpitations when taking Felodipin Hexal?

According to official adverse reaction lists, palpitations (a rapid or irregular heartbeat sensation) and an increase in heart rate (tachycardia) are classified as Common adverse reactions. These reactions are typically noted at the start of treatment.

Q: Is the headache side effect from Felodipin Hexal permanent?

Regulatory documents describe headache as a Very Common side effect when starting this medication. The official information notes that adverse reactions are often transient—meaning they appear predominantly at the start of treatment—and may lessen or resolve over time.

Q: Why does Felodipin Hexal commonly cause ankle and foot swelling (oedema)?

The swelling, known as peripheral edema, is the most common side effect and is dose and age-dependent. This occurs because the medicine selectively causes the relaxation and widening of the arterioles (small arteries), which is a localized effect and is not associated with generalized fluid retention.

Q: What is the most common reason for swelling of the ankles or feet when taking Felodipin Hexal?

Peripheral edema (swelling of the extremities) is officially listed as a Very Common adverse reaction, meaning it was the most frequently reported adverse event in clinical trials. This is the primary reason why patients notice swelling while taking the drug.

Q: Can Felodipin Hexal cause unusual tiredness or fatigue?

Official adverse reaction data classifies fatigue or unusual tiredness as a Common adverse reaction associated with this medicine.

Q: Is Felodipin Hexal a medication that is taken long-term?

Felodipin Hexal is primarily used to control high blood pressure and manage chronic stable angina. Given that these are typically long-term conditions, the therapy is generally required for long periods, reflecting the chronic nature of the condition.

Q: Can Felodipin Hexal be linked to instances of liver injury?

Regulatory data lists an increase in liver enzymes as a Very Rare adverse reaction, indicating an effect on the liver that is noted in safety data.

Q: Does Felodipin Hexal interact with alcohol consumption?

Official information indicates that alcohol may have an additive effect in lowering blood pressure. This potentiated effect may lead to increased symptoms such as dizziness or lightheadedness.

Q: Can Felodipin Hexal be taken safely alongside calcium supplements?

While Felodipine is a calcium channel blocker, studies have shown it may increase the body's calcium excretion. However, a reduction in effectiveness has not been noted in studies comparing felodipine use with calcium supplementation.

Q: What is known about the interaction between Felodipin Hexal and the herbal product St. John's Wort?

The official product information specifies that the herbal product St. John's Wort is a strong inducer of the CYP3A4 enzyme. Because Felodipine is metabolized by this enzyme, taking the two products together is avoided as it may result in a loss of efficacy (decreased levels of Felodipine in the body).

Q: What is the reason for the recommendation to check with a dentist regarding Felodipin Hexal?

Official information states that patients should be informed that mild gingival hyperplasia (gum swelling) has been reported as an adverse reaction. Official guidance notes that good dental hygiene may help to minimize the occurrence and severity of this effect.

Q: What is the potential link between Felodipin Hexal and gum swelling (gingival hyperplasia)?

Gingival hyperplasia, which is the medical term for gum enlargement or swelling, is officially listed as a Rare adverse reaction associated with this medication.

Q: Is a temporary worsening of chest pain possible when first starting Felodipin Hexal?

The regulatory documents list the worsening of Angina Pectoris as a potentially serious adverse reaction. Increased angina has been noted in patients during the initiation or dosage adjustment phase.

Q: What are the common non-serious symptoms that may resolve on their own after the initial weeks of treatment?

According to official safety information, side effects such as headache, flushing, and dizziness are often described as transient. These non-serious symptoms typically appear at the beginning of treatment and may lessen or resolve over the course of the initial adjustment period.

Q: Does Felodipin Hexal affect sleep or cause insomnia?

Adverse reaction data collected from official sources indicates that sleeplessness (insomnia) is a reported reaction associated with the use of this medicine.

Q: What is known about Felodipin Hexal's effects on sexual function or libido?

Impotence and general sexual dysfunction are officially listed in the adverse reaction data as Rare effects. Official post-marketing data also mentions a potential loss of interest in sexual intercourse.

Q: What is the reason that some people experience a feeling of being lightheaded or faint when standing up (orthostatic hypotension)?

Official prescribing information indicates that Felodipine may occasionally cause significant hypotension (low blood pressure), which can lead to lightheadedness or syncope (fainting). This effect is often most noticeable when transitioning quickly from a sitting or lying position to a standing position.

Q: Does taking Felodipin Hexal make a person more susceptible to sunburn?

Photosensitivity reactions (increased sensitivity to sunlight) are listed as a Very Rare adverse reaction in the official product information. Therefore, caution regarding UV exposure is often noted as a consideration.

Q: Does Felodipin Hexal contain lactose or other common allergens?

According to the official list of inactive ingredients, the tablets often contain excipients, including lactose monohydrate in certain strengths. This information is available in the regulatory documentation for formulation.

Q: Are there any specific foods that should be avoided besides grapefruit?

While grapefruit is explicitly prohibited because it inhibits the CYP3A4 enzyme, some sources suggest that other products that inhibit the same enzyme, such as pomegranate juice, may also require caution or avoidance.

Q: Can Felodipin Hexal be associated with joint pain?

Joint pain (arthralgia) is included in the adverse reaction data published in official documents.

Q: Does this medication cause constipation?

Adverse reaction data lists constipation as a reported gastrointestinal effect associated with the use of this medication (incidence less common).

Q: What is the purpose of the dyes or inactive ingredients in Felodipin Hexal?

The tablets contain inactive ingredients, known as excipients, which are used for several purposes. These ingredients, which can include coloring agents and substances like lactose monohydrate, are necessary to stabilize the tablet, ensure its integrity, and facilitate the specific extended-release function.

Q: Can Felodipin Hexal cause a cough?

Cough is listed in the adverse reaction data published in official regulatory documents (incidence less common).

Q: What are the signs of a serious allergic reaction to Felodipin Hexal described in official documents?

Potentially serious adverse reactions documented in official prescribing information include Angio-oedema (a serious hypersensitivity reaction), Myocardial infarction (heart attack), and the worsening of Angina Pectoris.

Storage and Disposal of Felodipine Hexal

Felodipine extended-release tablets must be stored at Controlled Room Temperature, which is specified as 20 C to 25 C (68 F to 77 F). The product must be protected from light, kept in a dry place, and the container should be kept tightly closed to maintain product integrity. The official label explicitly mandates that the medicine not be frozen.

Required Protection

Condition	Requirement
Temperature	Controlled Room Temperature
Light/Moisture	Protect from light; Store in a dry place
Prohibited	Do not freeze
Child Safety	Keep out of the sight and reach of children

For disposal, unused or expired Felodipine Hexal must be discarded in accordance with local requirements. The product must not be disposed of in household trash or flushed down the toilet, as instructed by regulatory documents for environmental protection.